Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.
Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF.
Bichoupan K, et al.
Aliment Pharmacol Ther. 2014 Jan;39(2):209-16. doi: 10.1111/apt.12560. Epub 2013 Nov 24.
Aliment Pharmacol Ther. 2014.
PMID: 24266536
Free PMC article.